107
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Patent strategy in Drug repurposing

      Published
      conference-abstract
      1
      REPO4EU
      RExPO23
      25-26 October 2023
      Patent, strategy, claim, repurposing, clinical trial, new indication, medical use, patient stratification, dosage regimen, sub-group
      Bookmark

            Abstract

            With an authorized repurposed medicine as the ultimate goal in focus, step by step and day by day executing essential steps of your strategy is key. These steps include the design of your preclinical R&D program relating to the new indication, selection of relevant and informative disease models, clinical trial design, and more, such as the stringent management of the what and when of the publication of the clinical trial protocol. During each aspect and step, one of the essentials is assessing whether and how your IP should be secured by filing patent applications on the right time. This, for example, as part of the purpose of raising the funds required for executing (phase III) clinical trials and more in general, having the resources for running your business. In addition, IP protection can be of utmost relevance for building a viable business model, especially when reimbursement is relatively on the low side.

            Content

            Author and article information

            Conference
            REPO4EU
            4 October 2023
            Affiliations
            [1 ] European Patent Attorney, Pharma/Life Sciences, NLO (NL) ( https://ror.org/016vvkz13)
            Article
            10.58647/REXPO.23018
            515faba5-ab96-4425-a9b4-3cbbfe9218d4
            Authors

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            RExPO23
            2
            Stockholm, Sweden
            25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Pharmacology & Pharmaceutical medicine
            Patent,strategy,claim,repurposing,clinical trial,new indication,medical use,patient stratification,dosage regimen,sub-group

            Comments

            Comment on this article